ID   LC-T
AC   CVCL_0B64
DR   Wikidata; Q54902126
RX   PubMed=1311980;
RX   PubMed=7736387;
RX   PubMed=10100721;
CC   Doubling time: 41.4 hours (PubMed=1311980).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
RX   PubMed=1311980; DOI=10.1002/1097-0142(19920415)69:8<2064::AID-CNCR2820690811>3.0.CO;2-#;
RA   Campling B.G., Haworth A.C., Baker H.M., Greer D.L., Holden J.J.A.,
RA   Bradley W.E.C., Pym J., Dexter D.F.;
RT   "Establishment and characterization of a panel of human lung cancer
RT   cell lines.";
RL   Cancer 69:2064-2074(1992).
//
RX   PubMed=7736387; DOI=10.1002/1097-0142(19950515)75:10<2442::AID-CNCR2820751009>3.0.CO;2-Q;
RA   Campling B.G., Sarda I.R., Baer K.A., Pang S.C., Baker H.M.,
RA   Lofters W.S., Flynn T.G.;
RT   "Secretion of atrial natriuretic peptide and vasopressin by small cell
RT   lung cancer.";
RL   Cancer 75:2442-2451(1995).
//
RX   PubMed=10100721;
RA   Young L.C., Campling B.G., Voskoglou-Nomikos T., Cole S.P.C.,
RA   Deeley R.G., Gerlach J.H.;
RT   "Expression of multidrug resistance protein-related genes in lung
RT   cancer: correlation with drug response.";
RL   Clin. Cancer Res. 5:673-680(1999).
//